HCMC is First to Offer New Medical Technology from Medtronic to Treat People Suffering from Incontinence

September 8, 2020

CUTLINE – Pictured is Dr. Mobley, III with reps from Medtronic with the new InterStim implant.  Dr Mobley is the first to implant an InterStim MRI SureScan lead and battery in West TN and Western KY.

The New FDA Approved InterStim™ Micro is the Smallest and Fastest Rechargeable Bladder and Bowel Control System with Conditional Full-Body MRI

Full-Body MRI Conditional InterStim™ II and InterStim™ Micro Systems Give Patients a Choice Between Sacral Neuromodulation Devices to Suit Their Lifestyle

PARIS, TN – Henry County Medical Center is one of the first medical providers in Tennessee to offer new solutions to the millions of people who suffer from incontinence thanks to technology advancements from Medtronic — the world’s leading provider of therapy for bladder and bowel control issues.

More than 37 million adults in the United States – almost one in six – suffer from overactive bladder (OAB) and nearly 18 million Americans – about one in 12 – have fecal incontinence (FI).1-4 It is life-altering because many sufferers limit their lives socially, professionally, and personally,5 but it is treatable.

The new InterStim™ II and InterStim Micro systems provide patients with safe, effective relief from OAB and FI. The InterStim™ II recharge-free system offers patients freedom from a recharging routine, the hassle of recharging components, and a reminder they have a disease. The rechargeable InterStim™ Micro system, the smallest device available in the sacral neuromodulation (SNM) market, benefits patients who want a smaller, longer lasting device. Both systems are full-body* conditional MRI and deliver the same therapy with long-term relief.

Drs. Joe Mobley, III and John Beddies of Kentucky Lake Urologic Associates are both now offering this new technology for treatment of incontinence.  Dr. Mobley was the first to implant an InterStim MRI SureScan lead and battery in West TN and Western KY.  Dr. Beddies was the first in the state of TN to implant the first MRI compatible lead.

“Effective long-term bladder and bowel control is an unmet medical need by many in the West TN area who experience regular accidents and/or frequency issues associated with OAB and FI. It can significantly impact all aspects of a person’s quality of life – self-confidence, exercise, activities and even intimacy,” said Joe Mobley, III, MD.  “By partnering with Medtronic, the trusted leader in SNM therapy, my goal is to help give patients a life without limits.”

Not every patient receives the same benefit, and there are potential risks, which may include surgical, device and stimulation risks.6   Kentucky Lake Urologic Associates will explain the benefits and risks and help each patient find their best treatment.

To learn more, go to our website at www.hcmc-tn.org or call Kentucky Lake Urologic Associates as 731-642-8884.  Watch a video describing the new technology by Drs. Mobley and Beddies:  https://youtu.be/HbhNTgA7XBs.  Also check us out on Facebook at https://www.facebook.com/KentuckyLakeUrologicAssociates.

Located in Paris, TN, Henry County Medical Center is a progressive, integrated healthcare organization committed to serving the healthcare needs of Henry County and the adjoining region.  Including a 142-bed hospital and other facilities, the medical center provides a variety of outpatient services, as well as inpatient care. Additionally, HCMC owns and operates 7 provider clinics in various specialties.  Henry County Medical Center is a county-owned and operated nonprofit institution. For more information: www.hcmc-tn.org.

*Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI leads only

References:

  1. Stewart WF, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May;20(6):327-336.
  2. United Nations, Department of Economic and Social A airs, Population Division (2011). World Population Prospects: The 2010 Revision, CD-ROM Edition.
  3. United States Quick Facts. United States Census Bureau Web site. Available at: https:// www.census.gov/quickfacts/table/ PST045215/00. Accessed July 19, 2016.
  4. Whitehead WE, Borrud L, Goode PS, et al. Fecal Incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137(2):512- 517.
  5. Dmochowski RR, Newman DK. Impact of overactive bladder on women in the United States: results of a national survey. Current Medical Research and Opinion. 2007;23:65-76.
  6. Link to Important Safety Information